Cargando…

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis

INTRODUCTION: Host blood transcriptomic biomarkers have potential as rapid point-of-care triage, diagnostic, and predictive tests for Tuberculosis disease. We aimed to summarise the performance of host blood transcriptomic signatures for diagnosis of and prediction of progression to Tuberculosis dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulenga, Humphrey, Zauchenberger, Chambrez-Zita, Bunyasi, Erick W., Mbandi, Stanley Kimbung, Mendelsohn, Simon C., Kagina, Benjamin, Penn-Nicholson, Adam, Scriba, Thomas J., Hatherill, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442252/ https://www.ncbi.nlm.nih.gov/pubmed/32822359 http://dx.doi.org/10.1371/journal.pone.0237574

Ejemplares similares

Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol
por: Mulenga, Humphrey, et al.
Publicado: (2019)

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Blood transcriptional signatures for tuberculosis testing
por: Mendelsohn, Simon C, et al.
Publicado: (2020)

Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Systematic review of diagnostic and prognostic host blood transcriptomic signatures of tuberculosis disease in people living with HIV
por: Mendelsohn, Simon C, et al.
Publicado: (2023)

Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Clinical predictors of pulmonary tuberculosis among South African adults with HIV
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Plasma Type I IFN Protein Concentrations in Human Tuberculosis
por: Llibre, Alba, et al.
Publicado: (2019)

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
por: Mulenga, Humphrey, et al.
Publicado: (2021)

Regional changes in tuberculosis disease burden among adolescents in South Africa (2005–2015)
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2020)

Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2022)

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
por: Sumner, Tom, et al.
Publicado: (2019)

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
por: Darboe, Fatoumatta, et al.
Publicado: (2019)

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
por: Scriba, Thomas J, et al.
Publicado: (2021)

Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Evaluation of Xpert(®) MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2015)

Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol
por: Bunyasi, Erick Wekesa, et al.
Publicado: (2017)

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
por: Penn-Nicholson, Adam, et al.
Publicado: (2020)

Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
por: Baguma, Richard, et al.
Publicado: (2021)

The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study
por: Sumner, Tom, et al.
Publicado: (2021)

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
por: Llibre, Alba, et al.
Publicado: (2022)

Inferring bona fide transfrags in RNA-Seq derived-transcriptome assemblies of non-model organisms
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2015)

A glance at quality score: implication for de novo transcriptome reconstruction of Illumina reads
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2014)

Tongue swab testing on two automated tuberculosis diagnostic platforms, Cepheid Xpert(®) MTB/RIF Ultra and Molbio Truenat(®) MTB Ultima
por: Wood, Rachel C., et al.
Publicado: (2023)

The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children
por: Mulenga, Humphrey, et al.
Publicado: (2015)

Considerations for biomarker-targeted intervention strategies for tuberculosis disease prevention
por: Fiore-Gartland, Andrew, et al.
Publicado: (2018)

Elevated IgG Responses in Infants Are Associated With Reduced Prevalence of Mycobacterium tuberculosis Infection
por: Logan, Erin, et al.
Publicado: (2018)

Cytomegalovirus infection is a risk factor for tuberculosis disease in infants
por: Müller, Julius, et al.
Publicado: (2019)

Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination
por: Bunyasi, E. W., et al.
Publicado: (2017)

Headway made towards biosignatures for incipient tuberculosis
por: Scriba, Thomas J, et al.
Publicado: (2020)

Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis
por: Burel, Julie G., et al.
Publicado: (2019)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
por: Satti, Iman, et al.
Publicado: (2022)

Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection
por: Duffy, Darragh, et al.
Publicado: (2020)

Host blood RNA signatures predict the outcome of tuberculosis treatment
por: Thompson, Ethan G., et al.
Publicado: (2017)

Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children
por: Luabeya, Kany Kany A., et al.
Publicado: (2015)

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
por: Baguma, Richard, et al.
Publicado: (2017)

Comparison of haematology and biochemistry parameters in healthy South African infants with laboratory reference intervals
por: Schmidt, B.‐M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_oqfstfh4viplkuk2kku00kq04d